Pathology and Forensic Medicine

A topic in the Science corpus, drawn from 3,205 papers.

Trusted voices in Pathology and Forensic Medicine

Ordered by the trust Pathology and Forensic Medicine's own network concentrates on each researcher, most first.

  1. M. F. Holick — trusted by 59 researchers here
  2. Jerzy Jurka — trusted by 42 researchers here
  3. Jörn Diedrichsen — trusted by 35 researchers here
  4. B. Hollis — trusted by 24 researchers here
  5. John Rognes — trusted by 13 researchers here
  6. D. Allan Butterfield — trusted by 16 researchers here
  7. D. Sidransky — trusted by 16 researchers here
  8. D. Yellon — trusted by 14 researchers here
  9. E. Brunt — trusted by 21 researchers here
  10. Larry Cahill — trusted by 15 researchers here
  11. Myron F. Goodman — trusted by 12 researchers here
  12. TA Wynn — trusted by 14 researchers here

Most-cited papers in Pathology and Forensic Medicine

Ordered by the recorded citation count from the source corpus; a citation is not an endorsement.

  1. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 (2010, International Journal of Cancer) — 21,956 citations
  2. Investigation of the freely available easy-to-use software ‘EZR' for medical statistics (2012, Bone Marrow Transplantation) — 17,041 citations
  3. Multiple Sclerosis (2007, Journal - Michigan State Medical Society) — 11,454 citations
  4. Mutations of the BRAF gene in human cancer (2002, Nature) — 10,701 citations
  5. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling (2000, Nature) — 10,272 citations
  6. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. (2011, Journal of Clinical Endocrinology and Metabolism) — 10,197 citations
  7. Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria (2011, Annals of Neurology) — 9,812 citations
  8. Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes (2016, Hepatology) — 9,590 citations
  9. Signatures of mutational processes in human cancer (2013, Nature) — 9,146 citations
  10. The Cancer Genome Atlas Pan-Cancer Analysis Project (2013) — 8,331 citations
  11. Polyphenols: food sources and bioavailability. (2004, American Journal of Clinical Nutrition) — 7,850 citations
  12. Comprehensive Molecular Characterization of Human Colon and Rectal Cancer (2012, Nature) — 7,754 citations
  13. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. (2005, The Lancet) — 7,387 citations
  14. Vitamin D deficiency. (2007, New England Journal of Medicine) — 7,203 citations
  15. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis (2001, Annals of Neurology) — 7,112 citations
  16. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. (2017, Lancet Neurology) — 6,885 citations
  17. A gene-expression signature as a predictor of survival in breast cancer. (2002, New England Journal of Medicine) — 6,396 citations
  18. Comprehensive molecular characterization of gastric adenocarcinoma (2014, Nature) — 5,955 citations
  19. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. (2004, New England Journal of Medicine) — 5,932 citations
  20. Mismatch-repair deficiency predicts response of solid tumors to PD-1 blockade (2017, Science) — 5,893 citations
  21. The Oswestry Disability Index. (2000, Spine) — 5,803 citations
  22. The International Classification of Headache Disorders: 2nd edition (2003) — 5,792 citations
  23. Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma. (2020, New England Journal of Medicine) — 5,608 citations
  24. Cancer Statistics, 2006 (2006, Ca) — 5,579 citations
  25. Binding of RHOA G17V to p300 enhances its HAT activity: a new mechanism of epigenetic deregulation in TFH lymphoma (2025, Blood Advances) — 5,541 citations
  26. Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. (2005, New England Journal of Medicine) — 5,515 citations
  27. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. (2002) — 5,458 citations
  28. Expert Commentary. (2002, Histopathology) — 5,260 citations
  29. Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria” (2005, Annals of Neurology) — 5,239 citations
  30. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials (2007) — 5,142 citations
  31. 5-Fluorouracil: mechanisms of action and clinical strategies (2003, Nature Reviews. Cancer) — 5,134 citations
  32. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. (2000, Pharmacological Reviews) — 5,077 citations
  33. Cisplatin in cancer therapy: molecular mechanisms of action (2014, European Journal of Pharmacology) — 5,019 citations
  34. Definition and classification of cancer cachexia: an international consensus. (2011, The Lancet Oncology) — 4,957 citations
  35. Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma (2017, New England Journal of Medicine) — 4,882 citations
  36. Sorafenib in advanced clear-cell renal-cell carcinoma. (2007, New England Journal of Medicine) — 4,849 citations
  37. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. (2014, Journal of Clinical Oncology) — 4,784 citations
  38. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17 (2005, Nature Immunology) — 4,711 citations
  39. Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. (2014, Physiological Reviews) — 4,703 citations
  40. The World Health Organization Classification of Lymphoid Neoplasms (2013) — 4,677 citations
  41. The Consensus Molecular Subtypes of Colorectal Cancer (2015, Nature Medicine) — 4,640 citations
  42. PD-1 Blockade in Tumors with Mismatch-Repair Deficiency (2015, New England Journal of Medicine) — 4,624 citations
  43. Revised response criteria for malignant lymphoma. (2007, Journal of Clinical Oncology) — 4,475 citations
  44. Plant polyphenols as dietary antioxidants in human health and disease (2009, Oxidative Medicine and Cellular Longevity) — 4,431 citations
  45. MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling (2007, Science) — 4,374 citations
  46. Abstract 5606: Detection of circulating tumor DNA in early and late stage human malignancies (2014) — 4,314 citations
  47. Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland. (2000, New England Journal of Medicine) — 4,264 citations
  48. Mutational landscape and significance across 12 major cancer types (2013, Nature) — 4,262 citations
  49. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. (2004, Blood) — 4,201 citations
  50. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. (2002, New England Journal of Medicine) — 4,196 citations

Most active researchers

By papers in this topic: a volume measure, not trust.